Z-L-aspartic acid β-tert.butyl ester monohydrate is a protected amino acid derivative in which L-aspartic acid is converted to the β-tert-butyl ester while the α-amino group is protected by a benzyloxycarbonyl (Z/Cbz) group. The molecule contains an esterified β-carboxyl functionality and a free carboxyl group for maintaining an amino acid-like bifunctional character, and it is provided as a monohydrate, which reflects the presence of associated water in the solid state. In peptide and amino acid synthesis workflows, this protected analogue is employed as a stepwise building block to control chemoselectivity of carboxyl reactivity and to support incorporation of aspartate side-chain functionality into peptide derivatives or related aspartyl-containing structures.
CAT No: CP00437
CAS No:5545-52-8
Synonyms/Alias:N,N'-Diacetyl-L-cystine;5545-17-5;N,N'-Diacetylcystine;DiNAC;AC1ODX85;SCHEMBL308082;C10H16N2O6S2;ZINC1737878;7487AH;AM20100361;K-9903;(2R)-2-acetamido-3-[[(2R)-2-acetamido-3-hydroxy-3-oxopropyl]disulfanyl]propanoicacid
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Read More